4D Molecular Therapeutics, Inc.
← Back to FDMT Overview

4D Molecular Therapeutics, Inc. (FDMT)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

5.60

Financial Fundamentals

FDMTQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2018-03-31-19.61
2018-06-30-19.61
2018-09-30-23.55
2018-12-31-23.55
2019-03-31-6.29
2019-06-30-6.29
2019-09-30-9.01
2019-12-31-9.32
2020-03-31-11.41
2020-06-30-9.91
2020-09-30-27.91
2020-12-31-13.46
2021-03-31-17.64
2021-06-30-21.21
2021-09-30-8.19
2021-12-31-5.91
2022-03-31-4.63
2022-06-30-2.01
2022-09-30-2.53
2022-12-31-6.59
2023-03-31-4.90
2023-06-30-5.85
2023-09-30-13.11
2023-12-31-6.14
2024-03-31-11.41
2024-06-30-8.44
2024-09-30-3.42
2024-12-31-1.51
2025-03-31-0.94
2025-06-30-0.95
2025-09-30-2.14
2025-12-315.60

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.